Posts by Muana Minkoué
Vandria secures $30.7 Million in Series A funding
Vandria secures $30.7 Million in Series A funding to advance groundbreaking mitophagy therapies. The Vaud-based company announced the second closing of its Series A financing, bringing the final amount raised to date to $30.7 Million (CHF 28.3 Million). Vandria welcomes new institutional investors Hevolution Foundation and Dolby Family Ventures, who have joined its…
Read MoreCSEM announced Andrea Dunbar as new CTO
CSEM announced the appointment of Andrea Dunbar as the new Chief Technology Officer (CTO), effective January 2025. Dunbar will succeed Harry Heinzelmann, who will retire on January 31, 2025, after an esteemed 27-year career with CSEM. Andrea Dunbar joined CSEM in 2007 as a physicist and scientist and has successfully driven innovation, particularly…
Read MoreBiopôle CEO interview with FutureHealth
Biopôle CEO, Nasri Nahas, talks innovation, disruptive models and technology ahead of FutureHealth Lausanne. Mr Nahas, how is Biopôle positioning itself in the Swiss innovation market and, looking ahead over the next five years, what specific goals are you pursuing? Innovation is not only about great ideas, it is about bringing those ideas…
Read MoreEPFL has developed a new AI approach to protein design
EPFL researchers have developed a novel AI-driven model designed to predict protein sequences from backbone scaffolds, incorporating complex molecular environments. It promises significant advancements in protein engineering and applications across various fields, including medicine and biotechnology. Designing proteins that can perform specific functions involves understanding and manipulating their sequences and structures. This task…
Read MoreRelease Therapeutics secures CHF 3.3 Million in seed funding
The Campus Biotech-based BioMedTech company announced the closure of a CHF 3.3 Million Seed financing round with private investors. The financing follows the Company’s first preclinical results in animal models of metachromatic leukodystrophy (MLD). MLD is a rare genetic disorder of the nervous system stemming from a deficiency in the lysosomal enzyme, arylsulfatase…
Read MoreSamanTree Medical raises $14 Million in Series B financing round
SamanTree Medical, a leading medical technology company specialising in innovative solutions to improve the outcomes of surgery, announced the closing of $14 Million as part of a Series B financing round. The new capital will be used to further develop and commercialise the Histolog® Scanner, expand its reach in Europe and the United…
Read MoreRelief Therapeutics secures up to $11 Million
Relief Therapeutics, a biopharmaceutical company committed to delivering innovative treatment options for select specialities, unmet and rare diseases, announced the signing and closing of a definitive agreement with SWK Funding LLC (SWK). The transaction provides the Campus Biotech-based company with non-dilutive funding to advance its pipeline, including the clinical development of its patent-protected…
Read MoreNew X-ray world record: looking inside a microchip with 4 nanometre precision
In a collaboration with EPFL Lausanne, ETH Zurich and the University of Southern California researchers at the Paul Scherrer Institute PSI have used X-rays to look inside a microchip with higher precision than ever before. The image resolution of 4 nanometres marks a new world record. The high-resolution three-dimensional images of the type…
Read MoreDigital Health Connect
The next Digital Health Connect is taking place on 4 December 2025, in Sion. Health through movement: between myth, science, and innovation The 13th edition of Digital Health Connect highlights movement as a therapeutic tool, a lever for prevention, and a driver of innovation. With sedentary lifestyles being one of the major public…
Read MoreAC Immune unveils novel therapeutic antibody drug conjugate (ADC)
AC Immune, unveiled a novel class of neurodegenerative disease-fighting drug-candidates called morADC (Morphomer® Antibody Drug Conjugate) in a presentation at the annual Alzheimer’s Association International Conference, in Philadelphia, PA. Dr. Madiha Derouazi, Chief Scientific Officer of AC Immune, presented the characterization and in vitro efficacy of morADC for the first time. The talk,…
Read More